CALR3
Basic information
Region (hg38): 19:16479061-16496167
Links
Phenotypes
GenCC
Source:
- hypertrophic cardiomyopathy (Disputed Evidence), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cardiomyopathy, familial hypertrophic, 19 | AD | Cardiovascular | Surveillance (eg, including echocardiography) for manifestations can allow early diagnosis, preventive measures relating to disease sequelae, and prompt treatment, which may reduce morbidity and mortality | Cardiovascular | 16199542; 17655857 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CALR3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 52 | 63 | ||||
missense | 122 | 128 | ||||
nonsense | 5 | |||||
start loss | 3 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 5 | 5 | 2 | 12 | ||
non coding | 25 | 30 | 55 | |||
Total | 0 | 0 | 144 | 82 | 40 |
Variants in CALR3
This is a list of pathogenic ClinVar variants found in the CALR3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-16479134-A-C | Hypertrophic cardiomyopathy 19 | Likely benign (Jun 21, 2020) | ||
19-16479139-C-T | Hypertrophic cardiomyopathy 19 • CALR3-related disorder | Uncertain significance (Nov 27, 2023) | ||
19-16479152-A-T | Hypertrophic cardiomyopathy 19 | Uncertain significance (Aug 04, 2023) | ||
19-16479153-AATTG-A | Hypertrophic cardiomyopathy 19 | Uncertain significance (Jan 17, 2023) | ||
19-16479155-T-C | Hypertrophic cardiomyopathy 19 | Uncertain significance (Dec 28, 2021) | ||
19-16479157-G-C | Hypertrophic cardiomyopathy 19 | Uncertain significance (Apr 26, 2023) | ||
19-16479157-G-T | Hypertrophic cardiomyopathy 19 | Uncertain significance (Oct 23, 2023) | ||
19-16479166-A-C | Hypertrophic cardiomyopathy 19 | Uncertain significance (May 09, 2021) | ||
19-16479172-C-A | Hypertrophic cardiomyopathy 19 | Uncertain significance (Nov 21, 2022) | ||
19-16479172-C-G | Hypertrophic cardiomyopathy 19 • not specified | Conflicting classifications of pathogenicity (Dec 21, 2023) | ||
19-16479172-C-T | Hypertrophic cardiomyopathy 19 | Uncertain significance (Aug 20, 2023) | ||
19-16479173-G-A | Hypertrophic cardiomyopathy 19 | Likely benign (Jan 22, 2022) | ||
19-16479176-C-T | Hypertrophic cardiomyopathy 19 | Likely benign (Dec 27, 2023) | ||
19-16479182-A-T | Hypertrophic cardiomyopathy 19 | Likely benign (Feb 15, 2017) | ||
19-16479191-C-G | Hypertrophic cardiomyopathy 19 | Likely benign (Jan 18, 2024) | ||
19-16479191-C-T | Hypertrophic cardiomyopathy 19 | Likely benign (Jul 10, 2023) | ||
19-16479192-G-A | Hypertrophic cardiomyopathy 19 | Uncertain significance (Jul 07, 2023) | ||
19-16479197-C-A | Hypertrophic cardiomyopathy 19 | Likely benign (Mar 06, 2020) | ||
19-16479199-G-A | Hypertrophic cardiomyopathy 19 | Benign (Jan 22, 2024) | ||
19-16479206-C-T | Hypertrophic cardiomyopathy 19 | Likely benign (Aug 01, 2021) | ||
19-16479216-TCG-T | Uncertain significance (-) | |||
19-16479217-C-T | Hypertrophic cardiomyopathy 19 • not specified | Uncertain significance (Oct 28, 2023) | ||
19-16479218-G-A | Hypertrophic cardiomyopathy 19 | Likely benign (Aug 14, 2023) | ||
19-16479219-C-A | Hypertrophic cardiomyopathy 19 • Cardiovascular phenotype • Primary dilated cardiomyopathy • not specified | Benign (Jan 31, 2024) | ||
19-16479219-C-T | Hypertrophic cardiomyopathy 19 | Uncertain significance (Aug 23, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CALR3 | protein_coding | protein_coding | ENST00000269881 | 9 | 17136 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.98e-10 | 0.435 | 125683 | 0 | 65 | 125748 | 0.000258 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.353 | 195 | 209 | 0.931 | 0.0000117 | 2561 |
Missense in Polyphen | 68 | 80.621 | 0.84345 | 1028 | ||
Synonymous | -0.215 | 87 | 84.5 | 1.03 | 0.00000581 | 650 |
Loss of Function | 1.05 | 17 | 22.4 | 0.760 | 0.00000117 | 246 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000565 | 0.000504 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000113 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000354 | 0.000352 |
Middle Eastern | 0.000113 | 0.000109 |
South Asian | 0.000295 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: During spermatogenesis, may act as a lectin-independent chaperone for specific client proteins such as ADAM3. Required for sperm fertility (By similarity). CALR3 capacity for calcium- binding may be absent or much lower than that of CALR. {ECO:0000250, ECO:0000269|PubMed:21590275}.;
- Disease
- DISEASE: Cardiomyopathy, familial hypertrophic 19 (CMH19) [MIM:613875]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:17655857}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- loftool
- 0.918
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.74
Haploinsufficiency Scores
- pHI
- 0.0992
- hipred
- N
- hipred_score
- 0.197
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.883
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Calr3
- Phenotype
- reproductive system phenotype;
Zebrafish Information Network
- Gene name
- calr3a
- Affected structure
- neuromast
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- protein folding;spermatogenesis;biological_process;cell differentiation
- Cellular component
- nuclear envelope;endoplasmic reticulum lumen
- Molecular function
- calcium ion binding;carbohydrate binding;protein folding chaperone;unfolded protein binding